Benzinga | Oct 13, 2020 04:03PM EDT

Enzo Biochem Q4 EPS $(0.07) Up From $(0.11) YoY, Sales $19.50M Miss $20.92M Estimate

Enzo Biochem (NYSE:ENZ) reported quarterly losses of $(0.07) per share. This is a 36.36 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $19.50 million which missed the analyst consensus estimate of $20.92 million by 6.79 percent. This is a 6.79 percent decrease over sales of $20.92 million the same period last year.